NCT01113216Enrolling by invitation
Genetic Modifiers of Cystic Fibrosis Related Diabetes
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This research is being done to find the genes and other factors that are responsible for differences among persons with cystic fibrosis. We are particularly interested in the factors that relate to the development of Cystic Fibrosis Related Diabetes (CFRD).
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 28 Apr 2010
- Start date
- Apr 2008
- Primary completion date
- Apr 2030
- Lead sponsor
- Johns Hopkins University
- Diseases
- Cystic fibrosis
- NCT number
- NCT01113216
What you commit to
- Study type: Observational
- Planned participants: 1500
- From Apr 2008 to the primary completion date, Apr 2030
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Any person with Cystic Fibrosis and his/her parents.
Age in the registry: 3 months to 99 years · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins Medicine Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| Children's Memorial Hospital Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.